Global Elastomers for Pharmaceuticals Market Research Report 2021

1 Elastomers for Pharmaceuticals Market Overview

• 1.1 Product Overview and Scope of Elastomers for Pharmaceuticals
• 1.2 Elastomers for Pharmaceuticals Segment by Type
  • 1.2.1 Global Elastomers for Pharmaceuticals Market Size Growth Rate Analysis by Type 2021 VS 2027
  • 1.2.2 Thermoset Elastomers
  • 1.2.3 Thermoplastic Elastomers
• 1.3 Elastomers for Pharmaceuticals Segment by Application
  • 1.3.1 Global Elastomers for Pharmaceuticals Consumption Comparison by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Stoppers
  • 1.3.3 Syringes
  • 1.3.4 Needle Shields
  • 1.3.5 Others
• 1.4 Global Market Growth Prospects
  • 1.4.1 Global Elastomers for Pharmaceuticals Revenue Estimates and Forecasts (2016-2027)
  • 1.4.2 Global Elastomers for Pharmaceuticals Production Capacity Estimates and Forecasts (2016-2027)
  • 1.4.3 Global Elastomers for Pharmaceuticals Production Estimates and Forecasts (2016-2027)
• 1.5 Global Market Size by Region
  • 1.5.1 Global Elastomers for Pharmaceuticals Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 2027
  • 1.5.2 North America Elastomers for Pharmaceuticals Estimates and Forecasts (2016-2027)
  • 1.5.3 Europe Elastomers for Pharmaceuticals Estimates and Forecasts (2016-2027)
  • 1.5.5 China Elastomers for Pharmaceuticals Estimates and Forecasts (2016-2027)
  • 1.5.5 Japan Elastomers for Pharmaceuticals Estimates and Forecasts (2016-2027)

2 Market Competition by Manufacturers

• 2.1 Global Elastomers for Pharmaceuticals Production Capacity Market Share by Manufacturers (2016-2021)
• 2.2 Global Elastomers for Pharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Elastomers for Pharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.4 Global Elastomers for Pharmaceuticals Average Price by Manufacturers (2016-2021)
• 2.5 Manufacturers Elastomers for Pharmaceuticals Production Sites, Area Served, Product Types
• 2.6 Elastomers for Pharmaceuticals Market Competitive Situation and Trends
  • 2.6.1 Elastomers for Pharmaceuticals Market Concentration Rate
  • 2.6.2 Global 5 and 10 Largest Elastomers for Pharmaceuticals Players Market Share by Revenue
  • 2.6.3 Mergers & Acquisitions, Expansion

3 Production and Capacity by Region

• 3.1 Global Production Capacity of Elastomers for Pharmaceuticals Market Share by Region (2016-2021)
• 3.2 Global Elastomers for Pharmaceuticals Revenue Market Share by Region (2016-2021)
• 3.3 Global Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.4 North America Elastomers for Pharmaceuticals Production
  • 3.4.1 North America Elastomers for Pharmaceuticals Production Growth Rate (2016-2021)
  • 3.4.2 North America Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.5 Europe Elastomers for Pharmaceuticals Production
  • 3.5.1 Europe Elastomers for Pharmaceuticals Production Growth Rate (2016-2021)
  • 3.5.2 Europe Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.6 China Elastomers for Pharmaceuticals Production
  • 3.6.1 China Elastomers for Pharmaceuticals Production Growth Rate (2016-2021)
  • 3.6.2 China Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
• 3.7 Japan Elastomers for Pharmaceuticals Production
  • 3.7.1 Japan Elastomers for Pharmaceuticals Production Growth Rate (2016-2021)
  • 3.7.2 Japan Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global Elastomers for Pharmaceuticals Consumption by Region

• 4.1 Global Elastomers for Pharmaceuticals Consumption by Region
  • 4.1.1 Global Elastomers for Pharmaceuticals Consumption by Region
  • 4.1.2 Global Elastomers for Pharmaceuticals Consumption Market Share by Region
• 4.2 North America
  • 4.2.1 North America Elastomers for Pharmaceuticals Consumption by Country
  • 4.2.2 U.S.
  • 4.2.3 Canada
• 4.3 Europe
  • 4.3.1 Europe Elastomers for Pharmaceuticals Consumption by Country
  • 4.3.2 Germany
  • 4.3.3 France
  • 4.3.4 U.K.
  • 4.3.5 Italy
  • 4.3.6 Russia
• 4.4 Asia Pacific
  • 4.4.1 Asia Pacific Elastomers for Pharmaceuticals Consumption by Region
  • 4.4.2 China
  • 4.4.3 Japan
  • 4.4.4 South Korea
  • 4.4.5 Taiwan
  • 4.4.6 Southeast Asia
  • 4.4.7 India
  • 4.4.8 Australia
• 4.5 Latin America
  • 4.5.1 Latin America Elastomers for Pharmaceuticals Consumption by Country
  • 4.5.2 Mexico
  • 4.5.3 Brazil

5 Production, Revenue, Price Trend by Type

• 5.1 Global Elastomers for Pharmaceuticals Production Market Share by Type (2016-2021)
• 5.2 Global Elastomers for Pharmaceuticals Revenue Market Share by Type (2016-2021)
• 5.3 Global Elastomers for Pharmaceuticals Price by Type (2016-2021)

6 Consumption Analysis by Application

• 6.1 Global Elastomers for Pharmaceuticals Consumption Market Share by Application (2016-2021)
• 6.2 Global Elastomers for Pharmaceuticals Consumption Growth Rate by Application (2016-2021)

7 Key Companies Profiled

• 7.1 Exxon Mobil Corporation
  • 7.1.1 Exxon Mobil Corporation Elastomers for Pharmaceuticals Corporation Information
  • 7.1.2 Exxon Mobil Corporation Elastomers for Pharmaceuticals Product Portfolio
  • 7.1.3 Exxon Mobil Corporation Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.1.4 Exxon Mobil Corporation Main Business and Markets Served
  • 7.1.5 Exxon Mobil Corporation Recent Developments/Updates
• 7.2 DuPont
  • 7.2.1 DuPont Elastomers for Pharmaceuticals Corporation Information
  • 7.2.2 DuPont Elastomers for Pharmaceuticals Product Portfolio
  • 7.2.3 DuPont Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.2.4 DuPont Main Business and Markets Served
  • 7.2.5 DuPont Recent Developments/Updates
• 7.3 BASF SE
  • 7.3.1 BASF SE Elastomers for Pharmaceuticals Corporation Information
  • 7.3.2 BASF SE Elastomers for Pharmaceuticals Product Portfolio
  • 7.3.3 BASF SE Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.3.4 BASF SE Main Business and Markets Served
  • 7.3.5 BASF SE Recent Developments/Updates
• 7.4 Dow
  • 7.4.1 Dow Elastomers for Pharmaceuticals Corporation Information
  • 7.4.2 Dow Elastomers for Pharmaceuticals Product Portfolio
  • 7.4.3 Dow Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.4.4 Dow Main Business and Markets Served
  • 7.4.5 Dow Recent Developments/Updates
• 7.5 Kuraray Co. Ltd
  • 7.5.1 Kuraray Co. Ltd Elastomers for Pharmaceuticals Corporation Information
  • 7.5.2 Kuraray Co. Ltd Elastomers for Pharmaceuticals Product Portfolio
  • 7.5.3 Kuraray Co. Ltd Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.5.4 Kuraray Co. Ltd Main Business and Markets Served
  • 7.5.5 Kuraray Co. Ltd Recent Developments/Updates
• 7.6 Lubrizol Corp
  • 7.6.1 Lubrizol Corp Elastomers for Pharmaceuticals Corporation Information
  • 7.6.2 Lubrizol Corp Elastomers for Pharmaceuticals Product Portfolio
  • 7.6.3 Lubrizol Corp Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.6.4 Lubrizol Corp Main Business and Markets Served
  • 7.6.5 Lubrizol Corp Recent Developments/Updates
• 7.7 Bailey-Parks Urethane Inc
  • 7.7.1 Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Corporation Information
  • 7.7.2 Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Product Portfolio
  • 7.7.3 Bailey-Parks Urethane Inc Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.7.4 Bailey-Parks Urethane Inc Main Business and Markets Served
  • 7.7.5 Bailey-Parks Urethane Inc Recent Developments/Updates
• 7.8 Covestro
  • 7.8.1 Covestro Elastomers for Pharmaceuticals Corporation Information
  • 7.8.2 Covestro Elastomers for Pharmaceuticals Product Portfolio
  • 7.8.3 Covestro Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.8.4 Covestro Main Business and Markets Served
  • 7.7.5 Covestro Recent Developments/Updates
• 7.9 Arkema Group
  • 7.9.1 Arkema Group Elastomers for Pharmaceuticals Corporation Information
  • 7.9.2 Arkema Group Elastomers for Pharmaceuticals Product Portfolio
  • 7.9.3 Arkema Group Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.9.4 Arkema Group Main Business and Markets Served
  • 7.9.5 Arkema Group Recent Developments/Updates
• 7.10 Hexpol Compounding
  • 7.10.1 Hexpol Compounding Elastomers for Pharmaceuticals Corporation Information
  • 7.10.2 Hexpol Compounding Elastomers for Pharmaceuticals Product Portfolio
  • 7.10.3 Hexpol Compounding Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.10.4 Hexpol Compounding Main Business and Markets Served
  • 7.10.5 Hexpol Compounding Recent Developments/Updates
• 7.11 Avient Corporation
  • 7.11.1 Avient Corporation Elastomers for Pharmaceuticals Corporation Information
  • 7.11.2 Avient Corporation Elastomers for Pharmaceuticals Product Portfolio
  • 7.11.3 Avient Corporation Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.11.4 Avient Corporation Main Business and Markets Served
  • 7.11.5 Avient Corporation Recent Developments/Updates
• 7.12 Teknor Apex Company
  • 7.12.1 Teknor Apex Company Elastomers for Pharmaceuticals Corporation Information
  • 7.12.2 Teknor Apex Company Elastomers for Pharmaceuticals Product Portfolio
  • 7.12.3 Teknor Apex Company Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.12.4 Teknor Apex Company Main Business and Markets Served
  • 7.12.5 Teknor Apex Company Recent Developments/Updates
• 7.13 Austin Novel Materials Co
  • 7.13.1 Austin Novel Materials Co Elastomers for Pharmaceuticals Corporation Information
  • 7.13.2 Austin Novel Materials Co Elastomers for Pharmaceuticals Product Portfolio
  • 7.13.3 Austin Novel Materials Co Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.13.4 Austin Novel Materials Co Main Business and Markets Served
  • 7.13.5 Austin Novel Materials Co Recent Developments/Updates
• 7.14 Huafon Group
  • 7.14.1 Huafon Group Elastomers for Pharmaceuticals Corporation Information
  • 7.14.2 Huafon Group Elastomers for Pharmaceuticals Product Portfolio
  • 7.14.3 Huafon Group Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.14.4 Huafon Group Main Business and Markets Served
  • 7.14.5 Huafon Group Recent Developments/Updates
• 7.15 Miracll Chemicals Ltd
  • 7.15.1 Miracll Chemicals Ltd Elastomers for Pharmaceuticals Corporation Information
  • 7.15.2 Miracll Chemicals Ltd Elastomers for Pharmaceuticals Product Portfolio
  • 7.15.3 Miracll Chemicals Ltd Elastomers for Pharmaceuticals Production Capacity, Revenue, Price and Gross Margin (2016-2021)
  • 7.15.4 Miracll Chemicals Ltd Main Business and Markets Served
  • 7.15.5 Miracll Chemicals Ltd Recent Developments/Updates

8 Elastomers for Pharmaceuticals Manufacturing Cost Analysis

• 8.1 Elastomers for Pharmaceuticals Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Key Raw Materials Price Trend
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Elastomers for Pharmaceuticals
• 8.4 Elastomers for Pharmaceuticals Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
• 9.2 Elastomers for Pharmaceuticals Distributors List
• 9.3 Elastomers for Pharmaceuticals Customers

10 Market Dynamics

• 10.1 Elastomers for Pharmaceuticals Industry Trends
• 10.2 Elastomers for Pharmaceuticals Growth Drivers
• 10.3 Elastomers for Pharmaceuticals Market Challenges
• 10.4 Elastomers for Pharmaceuticals Market Restraints

11 Production and Supply Forecast

• 11.1 Global Forecasted Production of Elastomers for Pharmaceuticals by Region (2022-2027)
• 11.2 North America Elastomers for Pharmaceuticals Production, Revenue Forecast (2022-2027)
• 11.3 Europe Elastomers for Pharmaceuticals Production, Revenue Forecast (2022-2027)
• 11.4 China Elastomers for Pharmaceuticals Production, Revenue Forecast (2022-2027)
• 11.5 Japan Elastomers for Pharmaceuticals Production, Revenue Forecast (2022-2027)

12 Consumption and Demand Forecast

• 12.1 Global Forecasted Demand Analysis of Elastomers for Pharmaceuticals
• 12.2 North America Forecasted Consumption of Elastomers for Pharmaceuticals by Country
• 12.3 Europe Market Forecasted Consumption of Elastomers for Pharmaceuticals by Country
• 12.4 Asia Pacific Market Forecasted Consumption of Elastomers for Pharmaceuticals by Region
• 12.5 Latin America Forecasted Consumption of Elastomers for Pharmaceuticals by Country

13 Forecast by Type and by Application (2022-2027)

• 13.1 Global Production, Revenue and Price Forecast by Type (2022-2027)
  • 13.1.1 Global Forecasted Production of Elastomers for Pharmaceuticals by Type (2022-2027)
  • 13.1.2 Global Forecasted Revenue of Elastomers for Pharmaceuticals by Type (2022-2027)
  • 13.1.3 Global Forecasted Price of Elastomers for Pharmaceuticals by Type (2022-2027)
• 13.2 Global Forecasted Consumption of Elastomers for Pharmaceuticals by Application (2022-2027)

14 Research Finding and Conclusion

15 Methodology and Data Source

• 15.1 Methodology/Research Approach
  • 15.1.1 Research Programs/Design
  • 15.1.2 Market Size Estimation
  • 15.1.3 Market Breakdown and Data Triangulation
• 15.2 Data Source
  • 15.2.1 Secondary Sources
  • 15.2.2 Primary Sources
• 15.3 Author List